Shanghai Fudan Zhangjiang Bio Pharmaceutical Co (DE:FDY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has announced a board meeting scheduled for August 12, 2024, to review and potentially approve the company’s unaudited interim financial results for the first half of the year and to discuss the possibility of declaring an interim dividend. The announcement highlights the board’s composition and reaffirms the company’s commitment to timely financial disclosures.
For further insights into DE:FDY stock, check out TipRanks’ Stock Analysis page.
